e-therapeutics plc (LON:ETX – Get Rating) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 16.22 ($0.20) and traded as low as GBX 12.77 ($0.16). e-therapeutics shares last traded at GBX 13.53 ($0.17), with a volume of 157,041 shares.
e-therapeutics Trading Down 7.2 %
The stock’s fifty day moving average price is GBX 13.52 and its 200 day moving average price is GBX 16.22. The stock has a market capitalization of £73.12 million, a P/E ratio of -676.25 and a beta of 0.51. The company has a debt-to-equity ratio of 2.03, a current ratio of 22.64 and a quick ratio of 20.13.
e-therapeutics Company Profile
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing.
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.